Trial Profile
The Study for Efficacy of Adalimumab Conbined Elemental Diet Therapy for Crohn's Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Dec 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 19 Dec 2018 Status changed from recruiting to completed.
- 14 Jun 2011 New trial record